JAK2 and essential thrombocythemia: Previous study showed that somatic mutations in CRT gene were identified in Janus kinase 2 gene (JAK2 V617F)-negative or MPL-negative primary myelofibrosis (PMF) and essential thrombocythemia (ET) patients.